DHEA Effects on Mood in Depressed HIV+ Patients
Please refer to this study by identifier 5800R
Principal Investigator(s)
Judith Rabkin
Purpose
The goal is to see whether DHEA, classified by the FDA as a nutritional supplement, is helpful in reducing depressive symptoms in older HIV+ patients with non-major depression.
Type of Study: Clinical Trial
Setting of Study: outpatient
Clinical Trials.gov number:
Providing Clinical Treatment?: Yes
No Cost Treatment?: Yes
Care is provided in languages: English
Study Activities
Filling Out Forms
Computer Tasks
Blood Samples
Provides Payment: Reimbursement for transportation
Provides Payment: Compensation for study related procedures
Eligibility
Ages Eligible for Study: 50 Years - 75 Years
Genders Eligible for Study: Both
This study is not recruiting Healthy Volunteers.
Criteria
Inclusion Criteria:
HIV+
age 50-75
medically stable
primary care doctor approves study participation
dysthymia or minor depression
willing and able to give informed consent
Location: 1051 Riverside Drive, Unit 51
NY NY 10032
Clinic: Depression Evaluation Service
Division:
Study chairs or principal investigators:
Judith Godwin Rabkin PhD, MPH, Principal Investigator
Co-investigators:
Martin McElhiney,
Richard Rabkin,
Patrick McGrath,
|
For more information, please contact
Judith Rabkin
Tel: 212 543 5762
E-mail: jgr1@columbia.edu
|
|